T1	Participants 123 214	Patients with early-stage breast cancer who are at substantial risk for systemic metastases
T2	Participants 390 506	Two hundred forty-four patients with stage I or II breast cancer who were at substantial risk for distant metastases
T3	Participants 616 653	All had had breast-conserving surgery
